BD and Biosero collaborate to integrate robotic automation with flow cytometry technology, aiming to accelerate drug discovery.

BD (Becton, Dickinson and Company) (NYSE: BDX), a leading global medical technology company, and Biosero, a developer of ...

In this article, Cerba dives into CAR+ T-cell therapy, from patient treatment to solutions for minimal residual disease (MRD) ...

BD. (BDX), a global medical technology company, and Biosero, a developer of laboratory automation solutions, Thursday announced that ...

BD, a global medical technology company, and Biosero, a developer of laboratory automation solutions, have joined forces to ...

They display data obtained by flow cytometry, a method for analyzing hundreds of thousands of individual cells based on their shape, consistency and other features. Once the domain of ...

Learn more about whether Bio-Rad Laboratories, Inc. or Danaher Corporation is a better investment based on AAII's A+ Investor ...

Dr. Christopher Flowers discusses MRD testing in cancer care, why this is an important concept to understand and how it ...

Trapped immune cells laden with microplastics starve the brain of oxygen—mouse study links vascular blockages to memory loss ...

Dr. Christopher R. Flowers delved into the meaning of MRD, discussing different ways that it may be tested for in patients ...